Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy - Wikidata - wikimedia - TriplyDB

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy

http://www.wikidata.org/entity/Q34869372

about

Serum uric acid predicts vascular complications in adults with type 1 diabetes: the coronary artery calcification in type 1 diabetes study ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.Intensive diabetes therapy and ocular surgery in type 1 diabetes.Estimated insulin sensitivity predicts incident micro- and macrovascular complications in adults with type 1 diabetes over 6 years: the coronary artery calcification in type 1 diabetes study.Inhibition of TLR4 alleviates the inflammation and apoptosis of retinal ganglion cells in high glucose.

P2860

Q31165772-B656A772-86C9-4E3C-9B23-E144870A0202 Q34614907-537DDC32-008A-498A-8AE1-C681DE0E4134 Q35734567-A622A2AB-1D6E-4736-BB42-5694006843A5 Q35943762-A23528EA-09D4-4090-BFE4-AB97E362A894 Q47951826-B699F0EF-CDA4-4A30-8743-F3C8758F51F0

P2860

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy

http://www.wikidata.org/entity/Q34869372

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy

@ast

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy

@en

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy

@nl

type

label

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy

@ast

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy

@en

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy

@nl

prefLabel

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy

@ast

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy

@en

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy

@nl

P1433

Q34869372-A5FD2EE0-DAB8-40EF-B49F-11054FBC0FE7

P1476

Q34869372-56287812-4791-4F56-83BE-869BEC731F93

P2093

Q34869372-2B8E5D4C-12E4-45BB-8D63-C9C06A047B8D

Q34869372-36EEE2BB-7006-451B-A4E0-4903105DC54F

Q34869372-3864291B-639A-48B7-AF66-33825923B089

Q34869372-5DD5A0A2-A2C5-4D8F-B1D9-C41397C09F5E

Q34869372-8B8EE836-41B5-446F-9787-942C065097AC

Q34869372-ACB414BB-A403-466A-BA96-6238A31F51A8

Q34869372-AF096F2D-504E-49FF-9D05-55F42D682B35

Q34869372-BAD5EDC2-2CBB-49AE-82DE-58CC7526056D

Q34869372-C7AD3AB3-A8D6-4A60-A8B7-F1E426AD23A1

Q34869372-D3D15A65-E5BF-4038-B8FA-4CFEDD3E429E

P2860

Q34869372-01515FC8-ECAD-4D6A-AFDE-0354DC18CFD1

Q34869372-164224D6-13DE-457B-A824-7895896C536A

Q34869372-27A95D5B-BAA3-449A-BE24-38678403C9FF

Q34869372-48E5CB6A-4BA6-449C-9166-ADCF1241F7B0

Q34869372-5A76EF4C-8885-4E33-9B0D-88B4B2405076

Q34869372-5C3861CF-DCA4-4ADC-8D37-B95A92275D12

Q34869372-6862A112-1405-4F0C-9F10-F6745F513636

Q34869372-869636AA-1EB9-489A-819B-6FC8C09C2272

Q34869372-90B8B9FC-8B82-48D0-8E12-247AA307215B

Q34869372-AFFD3282-05E8-427A-B417-098B3908B8A4

P304

Q34869372-1C9EE2A3-0BA1-4B8D-9C4E-B79A9A3034C5

P31

Q34869372-EE30C56A-B499-4922-8D39-E3FCC3B580BC

P356

Q34869372-E9A2D94B-56CE-473D-954B-0A323941470A

P433

Q34869372-6A954889-D700-4FDF-9DF2-887DF63971FE

P478

Q34869372-CA563203-7E75-4A2A-8143-8F0268E9BEF0

P50

Q34869372-44BC0B14-1B89-411E-8C63-5D991187B9B4

Q34869372-74B45EE8-A6F2-4D52-A8A1-97D794572FFD

P577

Q34869372-CAB78DF4-63B7-4196-AD3D-3F87DFB93B2D

P698

Q34869372-779BBA37-EF79-449B-9A5F-E7E93EFDB1C8

P932

Q34869372-FB5AD33C-B407-48A3-8621-C21F17223C75

P356

J.OPHTHA.2013.06.002

P1433

P1476

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy

@en

P2093

Andrew J Barkmeier

http://www.w3.org/2001/XMLSchema#string

Arghavan Almony

http://www.w3.org/2001/XMLSchema#string

DCCT/EDIC Research Group

http://www.w3.org/2001/XMLSchema#string

Larry Hubbard

http://www.w3.org/2001/XMLSchema#string

Matthew Davis

http://www.w3.org/2001/XMLSchema#string

Michael A Grassi

http://www.w3.org/2001/XMLSchema#string

Patricia A Cleary

http://www.w3.org/2001/XMLSchema#string

Ronald P Danis

http://www.w3.org/2001/XMLSchema#string

Sapna Gangaputra

http://www.w3.org/2001/XMLSchema#string

Szilárd Kiss

http://www.w3.org/2001/XMLSchema#string

P2860

The Measurement of Observer Agreement for Categorical Data

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results.

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Ranibizumab: in diabetic macular oedema.

Validity of self-reported eye disease and treatment in a population-based study: the Los Angeles Latino Eye Study

Genome-wide meta-analysis for severe diabetic retinopathy.

Patient self-report of prior laser treatment reliably indicates presence of severe diabetic retinopathy.

The prevalence of diabetic retinopathy among adults in the United States.

P304

2580-2586

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OPHTHA.2013.06.002

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23890420

http://www.w3.org/2001/XMLSchema#string

P932

3818390

http://www.w3.org/2001/XMLSchema#string